IRCT20201223049816N1招募中1 期
Evaluation of the effectiveness of PHR-160 spray in hospitalized COVID-19 patients with severe lung involvement in improving oxygen saturation; a randomized clinical trial study
Bagheiat-allah University of Medical Sciences0 个研究点目标入组 240 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 75 years（—）
- 性别
- All
入选标准
- •Ages 15-75
- •Oxygen saturation percentage between 88 and 93%.
- •Confirmation of 19 patients using RTPCR.
- •Confirmation of Covid-19 using CT scan
- •Signing a informed consent form
排除标准
- •Attending another trial in the last three months
- •pregnancy/lactation
- •drug sensitivity to the ingredients in the intervention
- •very high severity of the disease in the emergency room (consciousness less than 15 / oxygen concentration less than 88%, etc)
- •history of chronic respiratory disease
- •Previous pulmonary embolism (last three months)
研究者
相似试验
已完成
3 期
Effectiveness of PHR-160 spray in recovery of hospitalized patients with Covid-19 in Isfahan province in 1399IRCT20200411047029N1The Research Institute of Food and Secrets TAAMASRAR198
招募中
3 期
Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19IRCT20200731048257N1Bagheiat-allah University of Medical Sciences224
已完成
3 期
Evaluation of PHR160 spray effect on improvement of severe asthmatic patients.IRCT20220610055122N1Ahvaz University of Medical Sciences60
Unknown
不适用
Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19COVID-19NCT04463420Baqiyatallah Medical Sciences University224
尚未招募
2 期
Evaluation of the efficacy and safety of PR/HC/1718/001 in knee osteoarthritis.CTRI/2019/05/019179Aayush Healthcare